The Monogenetic Disease Therapy market was valued at USD 32.86 Billion in 2024 and is expected to reach USD 48.54 Billion by 2032, growing at a CAGR of 5% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.